Sheila Schatz
About Sheila Schatz
Sheila Schatz is a Logistics Specialist in Cell & Gene Therapy, currently employed at Adaptimmune in Philadelphia, Pennsylvania. She has extensive experience in logistics and supply chain management, having held various roles in the field since 2008.
Current Role at Adaptimmune
Sheila Schatz serves as a Logistics Specialist in Cell & Gene Therapy at Adaptimmune. She has been in this position since 2021, contributing her expertise in logistics and supply chain management specifically tailored to the cell and gene therapy sector. Her role involves managing logistics operations essential for the delivery and distribution of therapeutic products.
Previous Experience in Logistics
Before joining Adaptimmune, Sheila Schatz held several positions that enhanced her logistics skills. She worked as an Import Compliance Team Lead at BDP International from 2020 to 2021. Prior to that, she was a Transportation Manager at Sir Lancellot Courier from 2015 to 2018. Additionally, she served as a Logistics Coordinator at Biocair International from 2018 to 2020, further solidifying her experience in the logistics field.
Background in Freight Transportation
Sheila Schatz has a strong background in freight transportation, which has been instrumental in her logistics career. She began her journey in the logistics industry as a Customer Service Representative at Specialty Freight Services, Inc. from 2008 to 2011. This foundational experience has contributed to her ability to manage complex logistics operations effectively.
Education and Training
Sheila Schatz completed her education at Souderton High School, where she studied from 1985 to 1988. This educational background provided her with the foundational skills necessary for her subsequent career in logistics and supply chain management.
Skills in International Shipping
Sheila Schatz possesses specialized skills in international shipping and air freight. These skills are critical to her role as a Logistics Specialist, enabling her to navigate the complexities of global logistics in the cell and gene therapy sector.